at present , treatment with albendazole or mebendazole should be reserved for inoperable cases of cystic echinococcosis ( under strict medical supervision ) and individualized according to the patient 's response and the occurrence and severity of adverse reactions .
C0001911
albendazole
C0013502
echinococcosis